Information about Mifepristone for Medical Termination of …
Jan 17, 2025 · Mifeprex (mifepristone) and its generic, Mifepristone Tablets, 200 mg (collectively mifepristone) are approved, in a regimen with misoprostol, to end an intrauterine pregnancy …
Questions and Answers on Mifepristone for Medical Termination …
FDA approved a generic version of Mifeprex, Mifepristone Tablets, 200 mg, in April 2019. The agency’s approval of this generic reflects the FDA’s determination that Mifepristone...
Mifepristone is indicated, in a regimen with misoprostol, for the medical termination of intrauterine pregnancy through 70 days gestation. Risks to pregnant women are discussed throughout the...
Mifepristone's status is in question. Here's how the FDA handled ...
Apr 14, 2023 · When a federal judge in Texas ruled that the Food and Drug administration shouldn't have approved the abortion pill mifepristone in 2000, he agreed with arguments by …
The proposed goal of the modified REMS for mifepristone 200 mg is to mitigate the risk of serious complications associated with mifepristone by: Requiring healthcare providers who prescribe...
MEDICATION GUIDE Mifepristone (MIF-eh-pris-tone) tablets, 200 mg for oral use and misoprostol. It will help you understand how the
Updated Mifepristone REMS Requirements - ACOG
On January 3, 2023, updates to the U.S. Food and Drug Administration (FDA) risk evaluation and mitigation strategy (REMS) for mifepristone for reproductive health indications went into effect.
The FDA says mifepristone is safe. Here's the evidence - Los Angeles Times
Mar 26, 2024 · The FDA says it is aware of 32 women who died after taking mifepristone between September 2000 (when it was first approved in the United States) and the end of 2022.
Nov 12, 2004 · Mifeprex tablets each contain 200 mg of mifepristone, a synthetic steroid with antiprogestational effects. The tablets are light yellow in color, cylindrical and biconvex, and …
Texas judge says states can revive challenge to abortion pill …
Jan 16, 2025 · A federal judge in Texas is allowing three other states to pursue a challenge seeking to restrict access to the abortion pill mifepristone nationwide.